Basic and translational research in this field aims to repair heart injury and prevent the heart failure that often follows a heart attack.
Nearly 100,000 people in the United States have AE-IPF, and approximately 30,000 to 40,000 new cases are found each year.
The study concluded that participants were hesitant to receive the COVID-19 vaccine due to mistrust, fear and lack of information.
The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.
The Hugh Kaul Precision Medicine Institute will help build the interface of the Biomedical Data Translator, a “virtual brain” that will host all biomedical data in the world.
NIH selects UAB and UA as research sites for a longitudinal study on child development since pregnancy.
The 10-week trial will include meals provided by study investigators.
Young cancer survivors are at higher risk of developing subsequent HPV-related cancers than the general population, but less likely to receive the HPV vaccine. Findings from the first clinical trial of its kind support making HPV vaccination a routine part of oncologic care for all young cancer survivors, researchers say.
Release of TT-10 from nanoparticles improved heart function after a heart attack, accompanied by increased cardiomyocyte proliferation and smaller infarct size.
The NIH grant creates Multiple Chronic Disease Centers around the nation to target chronic disease in minority populations.
UAB researcher awarded NIH grant to research peer support for women living with hypertension and HIV
